Recent developments in the design of angiotensin‐converting enzyme inhibitors
- 1 October 1985
- journal article
- research article
- Published by Wiley in Medicinal Research Reviews
- Vol. 5 (4) , 483-531
- https://doi.org/10.1002/med.2610050405
Abstract
Click on the article title to read more.Keywords
This publication has 113 references indexed in Scilit:
- Ketomethyldipeptides I. A new class of angiotensin converting enzyme inhibitorsBiochemical and Biophysical Research Communications, 1984
- Azapeptides: A new class of angiotensin-converting enzyme inhibitorsBiochemical and Biophysical Research Communications, 1984
- Novel peptides with orally active and long-lasting antihypertensive activityBiochemical and Biophysical Research Communications, 1984
- Benzolactams. A new class of converting enzyme inhibitorsBiochemical and Biophysical Research Communications, 1983
- A new feature of angiotensin-converting enzyme in the brain: Hydrolysis of substance PBiochemical and Biophysical Research Communications, 1983
- Inhibition of procine kidney “enkephalinase” by substituted-N-carboxymethyl dipeptidesBiochemical and Biophysical Research Communications, 1982
- Metabolites of thyrotropin releasing hormone inhibit angiotensin converting enzyme invitroBiochemical and Biophysical Research Communications, 1982
- Inhibition of thermolysin by N-carboxymethyl dipeptidesBiochemical and Biophysical Research Communications, 1981
- Synthesis and angiotensin-converting enzyme inhibitory activity of 3-(mercaptomethyl)-2-oxo-1-pyrrolidineacetic acids and 3-(mercaptomethyl)-2-oxo-1-piperidineacetic acidsJournal of Medicinal Chemistry, 1981
- A crystallographic study of the complex of phosphoramidon with thermolysin. A model for the presumed catalytic transition state and for the binding of extended substratesJournal of Molecular Biology, 1977